Oxygen free radicals: Effects in the newborn period

Advances in Neonatal Care

Volumn 8, Issue 5, 2008, Pages 256-264

  Baba, Lisa ^a,b   McGrath, Jacqueline M ^c  

^a Phoenix College ^*  (United States)

^b Phoenix College   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antioxidant strategies; High risk infants; Oxygen free radicals; Premature infants

Indexed keywords

ANTIOXIDANT; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

ARTICLE; HUMAN; METABOLISM; NEWBORN; NEWBORN DISEASE; OXIDATIVE STRESS; PHYSIOLOGY;

ANTIOXIDANTS; FREE RADICALS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 65849101717     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ANC.0000338015.25911.8a     Document Type: Article

References (46)

1. Rodriguez R, Redman R. Balancing the generation and elimination of reactive oxygen species. Proc Natl Acad Sci. 2005;102(9):3175-3176.
2. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. 4th ed. New York: Oxford University Press; 2007.
3. Saugstad OD. Oxidative stress in the newborn-a 30-year perspective. Biol Neonate. 2005;88:228-236.
4. Dismukes GC, Klimov VV, Baranov SV, Kozlov YN, DasGupta J, Tyryshkin A. The origin of atmospheric oxygen on earth: the innovation of oxygenic photosynthesis. Proc Natl Acad Sci. 2001;98(5):2170-2175.
5. Blackburn S. Free radicals in perinatal and neonatal care, part 1. J Perinat Neonatal Nurs. 2005;19(4):298-300.
6. Jankov RP, Negus A, Tanswell KA. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res. 2001;50(6):681-687.
7. Melov S, Schneider JA, Day BJ, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet. 1998;18:159-163. doi:10.1038/ng0298-159.
8. Friel JK, Friesen RW, Harding SV, Roberts LJ. Evidence of oxidative stress in full-term healthy infants. Pediatr Res. 2004;56(6):878-882.
9. Buonocore G, Perrone S, Longini M, et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res. 2002;52(1):46-49.
10. Georgeson GD, Szony BJ, Streitman K, et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol. 2002;103(2):136-139.
11. Blackburn S. Free radicals in perinatal and neonatal care: part 2. J Perinat Neonatal Nurs. 2006;20(2):125-127.
12. Trindade CEP, Rugolo LMSS. Free radicals and neonatal diseases neo reviews. NeoReviews. 2007;8:e522-e532. doi:10.1542/neo.8-12e522.
13. O'Donovan DJ, Fernandes JC. Free radicals and diseases in premature infants. Antioxid Redox Signal. 2004;6:169-176.
14. Kajimoto H, Hashimoto K, Bonnet SN, et al. Oxygen activates the rho/rho-kinase pathway and induces rhob and rock-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species. A newly recognized mechanism for sustaining ductal constriction. Circulation. 2007;12:1777-1788.
15. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dis-mutase. Clin Invest. 1984;73:87-95.
16. Suresh GK, Davis JM, Soll RF. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev. 2001;1:CD001968. doi:10.1002/14651858.CD001968 .
17. Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 2006;8(2);E277-E283.
18. Buonocore G, Groenendaal F. Anti-oxidant strategies. Sem Fetal Neonatal Med. 2007;12:287-295.
19. Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;4:CD003665. doi:10.1002/14651858.CD003665.
20. Poston L, Briley AI, Seed PT, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VipTrial) randomized placebo-controlled trial. Lancet. 2006;367:1145-1154.
21. Rumbold AR, Crowther CA, Haslam RR, Deker GA, Robinson JS. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006;354:1796-1806.
22. Marzocchi B, Perrone S, Paffetti P, et al. Nonprotein bound iron and plasma protein oxidative stress at birth. Pediatr Res. 2005;58(6):1295-1299.
23. Wiedemann M, Kontush A, Finckh B, Wege HH, Kohlschuitter A. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res. 2003;53:843-849.
24. Kumar A, Pant P, Basu S, Rao GR, Khanna HD. Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr. 2007;53(1):69-71. doi:10.1093/tropej /fml060.
25. Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics. 2004;113(6):1776-1782.
26. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2007;4:CD000501. doi:10.1002/14651858.CD000501.
27. Greene HL, Phillips BL, Franck L, et al. Persistently low retinol levels during and after parenteral feeding of very low birthweight infants; examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsion. Pediatrics. 1987;79:894-900.
28. Ibrahim HM, Jeroudi MA, Baier RJ, et al. Aggressive early total parenteral nutrition in the low-birth-weight infants. J Perinatol. 2004;24(8):482-486.
29. Tan A, Schulze A, O'Donnell CPF, Davis PG. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev. 2005;2:CD002273. doi:10.1002/14651858.CD002273.pub3.
30. Vento M, Asensi M, Sastre J, Garcia-Sala, Pallardo FV, Vina J. Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics. 2001;107(4):642-647.
31. Escrig R, Arruza L, Izquierdo I, et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentration: a prospective, randomized trial. Pediatrics. 2008;121:875-881.
32. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOPROP), a randomized, controlled trial: primary outcomes. Pediatrics. 2000;105:295-310.
33. Clucas L.,Doyle L.W.,Dawson J.,Donath S.,Davis P.G.Compliance with alarm limits for pulse oximetry in very preterm infants. Pediatrics 2007; 119; 1056-1060.
34. Clucas L, Doyle LW, Dawson J, Donath S, Davis PG. Compliance with alarm limits for pulse oximetry in very preterm infants. Pediatrics. 2007;119:1056-1060. 34. Castillo A, Sola A, Baquero H, et al. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: Is 85% to 93% an acceptable range? Pediatrics. 2008:121;882-889.
35. Baird LL. Protecting TPN and lipid infusions from light: reducing hydroper-oxides in NICU patients. Neonatal Netw. 2001;20(2):17-22.
36. Picaud JC, Steghens JP, Auxenfans C, Barbieux A, Laborie S, Claris O. Lipid peroxidation assessment by malondialdehyde measurement in parenteral nutrition solutions for newborn infants: a pilot study. Acta Paediatr. 2004;93:241-245.
37. Wardle SP, Drury J, Garr R, Weindling AM. Effect of blood transfusion on lipid peroxidation in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86:F46-F48.
38. Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol. 1995;50(11):1749-1752.
39. National Library of Medicine (Content source); Emily Monosson (Topic ed.). Biotransformation. In: Cutler J, ed. Encyclopedia of Earth. Cleveland CJ, ed. Washington, DC: Environmental Information Coalition, National Council for Science and the Environment. http://www.eoearth.org/article/ Biotransformation. Accessed August 27, 2008.
40. Schacht J. Antioxidant therapy attenuates aminoglycoside-induced hearing loss. Ann N YAcadSci. 1999;884:125-130.
41. Evans P, Halliwell B. Free radicals and hearing: cause, consequence, and criteria. An N Y Acad Sci. 1999;884(1):19-40. doi:10.1111/j.1749-6632. 1999.tb08633.x.
42. Sha SH, Qiu JH, Schacht J. Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med. 2006;354(17):1856-1857.
43. Kalinec GM, Fernandez-Zapico ME, Urrutia R, Esteban-Cruciani N, Chen S, Kalinec F. Pivotal Role of Harakiri in the Induction and Prevention of Gentamicin-Induced Hearing Loss. Communicated by Thomas S. Reese. Bethesda, MD: National Institutes of Health; September 14, 2005. www.pnas.org/content/102/44/ 16019.full. Accessed January 5, 2005.
44. Wang AM, Sha SH, Lesniak W, Schacht J. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother. 2003;47(6):1836-1841.
45. Pineiro-Carrero VM, Pineiro EO. Liver. Pediatrics. 2004;113(4):1097-1106.
46. Friel JK, Martin SM, Langdon M, Herzberg GR, Buettner GR. Milk from mothers of both premature and full-term infants provides better antioxi-dant protection than does infant formula. Pediatr Res. 2002;51(5): 612-618.